chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was sitting on exam table to receive both the tdap and flu vaccines. Verified pt's name and DOB before giving the vaccines. Patient was given the flu vaccine in his right upper arm after area had been cleaned with aseptic and a minute later the tdap vaccine was given in a different spot on his right upper arm. Patient passed out and loss consciousness for about 2 minutes (definitely less than 5 minutes) immediately after receiving the tdap vaccine. When patient passed out, he fell face forward from the exam table and hit his head on the floor. The force from his glasses smashing against his face created a laceration above his left eyebrow. The glasses broke on the left side as well. The laceration was approximately 4 cm in length and less than 1 cm in depth and well- approximated. Cleaned the laceration with hibiclens solution, dried area, placed bacitracin ointment and covered laceration with gauze. Patient monitored in the clinic for 1.5 hours while waiting on his mom to arrive who lived an hour away. Pt closely monitored after fall. Vital signs stable throughout the entire episode. Hemostasis obtained. Patient remained neurologically intact. No evidence of concussion or headache, just pain around laceration site. Mother did not want ambulance called. Recommended that patient be taken to an urgent care or the ER to get laceration above left eyebrow stitched up. Mother verbalizes understanding and is in agreement to plan of care.
Hives appearing throughout the day,  worst at night. Basic Anti-histamines solve the issue for the day.
At 09:21 am Stated tightness in throat, diaphoresis, and nausea. At 09:24 am was given; 1 ml Benedryl IM left deltoid. Started feeling relief at 09:30 am, then approximately 14 minutes later had tightness in throat again, stated having no difficulty breathing or swallowing. Called 911 at 09:45 am. O2 sat and heart rate were within normal range, elevated BP 153/93 lying and 163/103 sitting left arm. Agreed to go to ED with medical team at 09:55 am. walked out with paramedic.
on day 8 after receiving moderna shot i woke up where my injection sight was with a big, red, hot swollen rash. today 9 the rash is getting bigger and worse. no appetite, very tired, light headed
Vaccine administered on 04/28/2009. Within 24 hours swelling, fever at injection site, tenderness,and increasing redness appeared. Within 48 hours the redness, fever at site with swelling and pain continue.  On Friday morning 05/01/2009 I woke up with an extreme case of vertigo with nausea.
More fatigue after 3rd dose than the others; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (More fatigue after 3rd dose than the others) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (More fatigue after 3rd dose than the others). At the time of the report, FATIGUE (More fatigue after 3rd dose than the others) had resolved.            No Concomitant medications were provided No treatment medications were provided.   This case was linked to MOD-2021-353899, MOD-2021-353900 (Patient Link).
chills and body aches starting at 3:30 am lasting throughout the day. injection site soreness and axillary lymph node soreness
Information has been received from a medical assistant referring to a 65 year old female patient with hypertension. The patient's concomitant medication and drug reactions/allergies were unknown. On 11-NOV-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # L035686 with expiration date 16-FEB-2017; dose and route were unknown). On an unknown date in November 2015, the patient had localized swelling and soreness at the injection site. On 13-NOV-2015, the patient contacted an unspecified physician and was prescribed an unspecified dose of ibuprofen (manufacture unknown). No lab diagnostics studies were performed. The events were resolved on an unknown date. The causality was not reported. Additional information has been requested.
8/10/21- headache, rapid heart rate, burning eyes, sore throat, 8/11/21 - pt noticed rash on both arms, rash started spreading. 8/12/21 - pt went to urgent care and was given an antihistamine. Patient doesn't remember the name of antihistamine. She only knows it was not Benadryl.  The rash has partly gone away by 8/13/21.
Adverse events: Pain at injection site, headache, nausea, fatigue, malaise, and chills.   Treatment: took Tylenol 1 gram by mouth once at bedtime. Outcome: symptoms were alleviated by Tylenol.
Initially localized reaction with redness at injection site: sore, inflamed, tender. Subsequent days the reaction spread towards 2 inches below left elbow. Complained of tenderness and pruritis.
Initial report received from non-healthcare professional on 16 October 2012. A 04 year old male patient whose medical history include sclera derma and allergic to amoxicillin and concomitant medications were not reported had received intramuscular DAPTACEL (batch number, site of administration, dose, dose number not reported) on 12 October 2012. It was reported that, 2 days after vaccination on 14 October 2012, the patient complained that his tongue burns which was seen by his MD who felt tongue was little red and might be irritated by food. The patients mother stated that whenever he eats even cold food the patient claims his tongue burns. The patients tongue was not blistered or swollen. The patient received vaccine due to laceration on his foot. Details of corrective treatments and laboratory investigations were none. The outcome of the event was not recovered. Documents held by sender: none. Follow-up information received from a healthcare professional on 02 January 2013. The patient had received DAPTACEL vaccine with Lot no: C4154BA in left leg.
Information has been received from a a physician concerning a 6 year old male who was previously vaccinated with two doses of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). In April 2006, the patient experienced a severe case of mumps. It was reported that the child has swelling on both sides and it is considered a clinically significant case. A serology and IGG were done. A IGM was high and follow up was scheduled for 24-APR-2006. At the time of this report the patient had not recovered. It was noted that the child's 3 year old sibling only received one shot of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) and does not have the mumps. Unspecified medical attention was sought. No product quality involved. Additional information has been requested.
Erythema, induration, itching (L) deltoid area at site of injection, left upper arm.
relapse from 0% immature blast cells back to 25 %/AML; Nasty anaphylactic reactions; Night sweats; weight loss; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE MYELOID LEUKAEMIA (relapse from 0% immature blast cells back to 25 %/AML) and ANAPHYLACTIC REACTION (Nasty anaphylactic reactions) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Acute myeloid leukemia (AML). Concomitant products included VENETOCLAX (VENCLEXTA) and DECITABINE (DACOGEN) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACUTE MYELOID LEUKAEMIA (relapse from 0% immature blast cells back to 25 %/AML) (seriousness criterion medically significant), ANAPHYLACTIC REACTION (Nasty anaphylactic reactions) (seriousness criterion medically significant), NIGHT SWEATS (Night sweats) and WEIGHT DECREASED (weight loss). At the time of the report, ACUTE MYELOID LEUKAEMIA (relapse from 0% immature blast cells back to 25 %/AML), ANAPHYLACTIC REACTION (Nasty anaphylactic reactions), NIGHT SWEATS (Night sweats) and WEIGHT DECREASED (weight loss) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Weight: loss (Low) weight loss.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided by the reporter.  The patient had weigh loss, night sweats, nasty anaphylactic reactions, relapse from  0% immature blast cells back to 25%.  Company comment: This case concerns a patient with unknown name, date of birth and gender, with no previous relevant medical history, who experienced the expected event of Anaphylactic reaction, night sweat and AML reaggravated. . The event occurred after the dose of Spikevax. The rechallenge was not applicable since no information about the first dose or  the second dose was disclosed. The benefit-risk relationship of Spikevax is not affected by this report.; Sender's Comments: This case concerns a patient with unknown name, date of birth and gender, with no previous relevant medical history, who experienced the expected event of Anaphylactic reaction, night sweat and AML reaggravated. . The event occurred after the dose of Spikevax. The rechallenge was not applicable since no information about the first dose or  the second dose was disclosed. The benefit-risk relationship of Spikevax is not affected by this report.
Patient felt lightheadedness and dizziness; Feeling like' something around my head'; Patient felt itching around the injection site; Patient felt tiredness; Patient felt weak; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Patient felt weak), DIZZINESS (Patient felt lightheadedness and dizziness), FEELING ABNORMAL (Feeling like' something around my head'), VACCINATION SITE PRURITUS (Patient felt itching around the injection site) and FATIGUE (Patient felt tiredness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Allergic reaction (patient do not take FLU vaccine because of some allergic reactions). Concomitant products included MONTELUKAST SODIUM for Allergy, CALTRATE + D PLUS for Osteoporosis, MESALAZINE (APRISO), OLMESARTAN, ATORVASTATIN, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (FLUTICASONE PROPIONATE/SALMETEROL), LATANOPROST and CENTRUM SILVER +50 for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ASTHENIA (Patient felt weak), VACCINATION SITE PRURITUS (Patient felt itching around the injection site) and FATIGUE (Patient felt tiredness). On 21-Mar-2021, the patient experienced DIZZINESS (Patient felt lightheadedness and dizziness) and FEELING ABNORMAL (Feeling like' something around my head'). At the time of the report, ASTHENIA (Patient felt weak), DIZZINESS (Patient felt lightheadedness and dizziness), FEELING ABNORMAL (Feeling like' something around my head'), VACCINATION SITE PRURITUS (Patient felt itching around the injection site) and FATIGUE (Patient felt tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.  Patient one hour after the 1st shot patient felt weak and tiredness and symptoms like itching around the injection site. On 21Mar2021, patient woke up with fatigue, weakness, lightheadedness and dizziness. Because of the symptom's patient tried to remain in the bed for 30 - 45 minutes because of feeling like' something around my head.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: The physician stated that the patient did not report the symptoms to his clinic.
SEVERE swelling of tongue, lips, mouth lining, throat; "waxy coating feeling" in lungs - began 20 minutes after vaccination to 4 days after - went to Emergency Department at 30 minutes after vaccination and received IV medication and epipen shot to R thigh.  Subsided before leaving ED, but returned in more mild state the next day - managed by OTC Benadryl and allergy meds. Symptoms returned again at approx 39 hours and returned to Emergency Department again for more IV medications. Asthma attacks - started in the Emergency Department on first day and have continued to today 3/3/2021. Prior to vaccination, I used inhaler approx 1x every 60 days at most.  Have gone more than a year without using one.  After vaccination, used inhaler the same evening and then 12 times the next day, and several times before going to ED again, and have had to use it daily since.  This morning 3/3/2021, woke at apprise 2:30-3:00 am with an attack that needed 2 doses to subside, and then again at 8:30 this am about 1.5 hours after waking.  Burning on tongue with sores on outer sides, metallic/burning/no taste - began 20 minutes after vaccination continuing to today. Rash on face - began in Emergency Department on first day and continues to today. Began using Cortizone yesterday 3/3/2021. Rash and hives on neck, chest - began in Emergency Department on first day and subsided next day after allergy medications in ED and OTC allergy medications that night. Headache - sudden onset 25 minutes after vaccination.  Returned that evening after first ED visit. Returned the following day. Returned the third day. Subsided the fourth day. Used ibuprofen and acetaminophen to manage.
On 5/29/08 he developed 100 temp have maculopapular rash at face (behind ears) first spreading and torso, extremities. A few lesions at face and extremities papulo postor ear.
HYPERtension  FLUSHED, HOT, NUMBNESS AROUND MOUTH, DIAPHORETIC, HEAVINESS IN STOMACH, BP 157/90 RETURNED 135/82 @ 0820  Narrative:
Per mother pt received Meningitis and Meningitis B vaccines on 3/9/2023. The following day she felt tired and then short of breath with heart racing and chest discomfort.  She presented  to the EC and was found to have elevated D  dimer and elevated but indeterminate troponin.  She also has elevated sed rate and CRP.  She is currently admitted in stable condition
On 09/27/2022 I had nausea, runny nose, cough and low energy. I tested positive on 09/29/2022. I spoke with my doctor 2 times when I tested positive. On 10/12/2022 I went to my doctor for a regular check up and she prescribed me  medications for my COVID-19 symptoms which are azithromycin and cough syrup. She also gave me steroid shot.
Hive rash began about 2/12/10. Weak upper leg muscles, uncomfortable sitting for extended time. Difficulty rising from chair or couch. Hive like rash extended over entire torso. Treated with steroids on 3/12/10. Muscle weakness began in January 2010.
This spontaneous report was received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. No pertinent medical history, concurrent conditions or drug reactions/allergies were reported. On an unspecified date, since 01-AUG-2015, patients were vaccinated with VAQTA (dose, frequency and route of administration were not provided), lot # K019560, expiration date 02-JUN-2017; lot # L002717, expiration date 02-JUN-2017 and lot # K012457, expiration date 04-JUN-2017. No concomitant medication was reported. At the time of this report, no adverse effects were reported. This is one of the several reports received from the same source. Additional information has been requested.
Anxiety; Panicked Feeling; Panicked Feeling; upset/mad; Chills; This is a spontaneous report from a contactable consumer (patient).   A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 20Apr2021 09:30 (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history included panicked feeling and stopped on unknown date. Concomitant medications were not reported. The patient previously received the first dose of  BNT162B2 for COVID-19 Immunization and experienced Sore Arm. The patient stated she seemed alright on 20Apr2021. She had chills in the evening 20Apr2021 and took Tylenol and drank water like she was told. this morning on 21Apr2021 she had anxiety. A panicked feeling. She hasn't felt that way in years and felt that how she was feeling now was most likely due to the vaccine. She became upset she even got the vaccine and stated she was mad. The events outcome was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient came in for Pfizer Bivalent booster, but was given Pfizer primary series instead. Patient had no adverse events and CDC recommendations are re-vaccination is uneccasry
fever; pain; aching; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), PAIN (pain) and PAIN (aching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), PAIN (pain) and PAIN (aching). At the time of the report, PYREXIA (fever), PAIN (pain) and PAIN (aching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX lot # M047662, expiration date 02-DEC-2018 (dose and route of administration were not reported). The vaccine was reconstituted with properly stored sterile diluent (manufacturer unknown) (lot# and expiration date were not reported). No adverse effects were reported. Administered doses of vaccines experienced the temperature excursion between 9 and 25 degrees Celsius for 2 hours 16 minutes. Data logger was involved. There were no previous excursions reported. Additional information has been requested.
COVID Arm. 8 days after the vaccine. large red oval at the site of the vaccination (2 in x 5 in).  Enlarged and painful lymph node in the left arm pit (same side as vaccine).
Parent had multiple children with her.  Parent confirmed all children were 12 years of age or older. Patient was given Pfizer vaccine.  When entered into database it was noticed that the patients birthday was 11/08/2009.
BlurredVision, Confusion & Headache Narrative: Shortly after the patients first vaccination of COVID, she began to experience double vision, headache and vision loss. To this date, she still has double vision that fluctuates and loss of vision and has been using reading glasses which seem to help. She has been going to vision therapy and seeing a neurologist.
Information has been received from a physician concerning a female who was vaccinated with her first dose of GARDASIL. Subsequently the patient experienced a rash on her arms, back and thighs shortly after being vaccinated. Her outcome was not reported. Additional information received 18-JAN-2008: The case concerned a patient who developed a pruritic rash below the injection site, also involving the opposite leg and back. The rash developed several days after vaccination and was not associated with any other complaints . This was not felt to be hypersensitivity reaction. The physician will discuss giving the second dose in the series with the patient and closely observe her. Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/14/2008. Follow-up information indicated that the patient developed rash on left foream (vaccinated left deltoid) and rash on right leg and partial back. On 08-Nov-2007, the patient was vaccinated with her second dose of GARDASIL vaccine (lot# 659055/1522U) and no reaction was reported.
Pt started with temperature of 101, then by Tuesday Am 10/20/09 fever up to 104.
Three months after I received my booster dose I contracted COVID-19. I have been struggling with fatigue and have post menopausal spotting after not having a menstrual cycle for 15 years.
Patient stated she felt hot, uncomfortable, and then weak. She stated that her vision was blurry and then lost consciousness. Her body jerked twice and within 30 seconds she awoke feeling nauseated and weak.
Pt received shot about 3:00 at about 7:30-8:00pm she started complaining of chest pain and hard to breathe. She also had a temp and lose of appetite taken to ER.
Anaphylactic Reaction: Laryngealspasm, chest tightness, globus sensation and Urticaria
CoughWheeze Narrative:  Hx of Asthma, uses Albuterol inhaler. Noted some wheezing w/o distress. Able to speak freely. Wheezes cleared after cough
4JUN94 8PM very fussy, no fever; 9PM or 10PM devel muscle contractions or spasms which lasted until 4AM when they gradually subsided; did not appear to be true convuls; went to ER seen by nurse;
On 11/8/2012 pt. called to report that despite Tdap in April given postpartum she was diagnosed with pertussis & lab work reveals no immunity. She and her 7 month old child on antibiotics. Vaccine given on 4/4/12 Lot #AC52B078BA Glaxo Exp. date 11/25/13.
multiple place joint pains and balance issue; I went to see pain management doctor and he recommends to follow up with a rheumatologist and neurologist.
Swollen lymph node; This case was reported by a consumer via interactive digital media and described the occurrence of enlargement of lymph nodes in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced enlargement of lymph nodes. On an unknown date, the outcome of the enlargement of lymph nodes was unknown.   It was unknown if the reporter considered the enlargement of lymph nodes to be related to Shingrix.   Additional Information: GSK Receipt Date: 14-APR-2022 Reporter's Comment: This case was reported by a consumer via interactive digital media. The patient experienced swollen lymph node. Additional Supportive Information: The follow up would not possible as no contact details were available.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Seizure-Medium, Additional Details: patient fainted and hit head on chair when falling from sitting in chair to floor.  bystander said that patient's entire body was convulsing. pharmacist ran out to patient and by the time rph was by his side he was awake and coherent. EMT came and checked patient out, advised patient to go to hospital for monitoring but patient refused. patient's mother came and picked him up.